Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Operating Margin 2017-2025 | ORINY

Current and historical operating margin for Orion OYJ (ORINY) over the last 10 years. The current operating profit margin for Orion OYJ as of June 30, 2025 is 22.61%.
  
Orion OYJ Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $1.83B $0.52B 28.46%
2025-03-31 $1.71B $0.47B 27.65%
2024-12-31 $1.67B $0.45B 27.04%
2024-09-30 $1.55B $0.45B 29.25%
2024-06-30 $1.36B $0.32B 23.42%
2024-03-31 $1.33B $0.30B 22.57%
2023-12-31 $1.29B $0.30B 23.06%
2023-09-30 $1.25B $0.25B 19.62%
2023-06-30 $1.42B $0.41B 28.57%
2023-03-31 $1.41B $0.44B 31.41%
2022-12-31 $1.41B $0.46B 32.77%
2022-09-30 $1.42B $0.46B 32.32%
2022-06-30 $1.21B $0.28B 23.13%
2022-03-31 $1.21B $0.28B 22.96%
2021-12-31 $1.23B $0.29B 23.40%
2021-09-30 $1.22B $0.29B 23.63%
2021-06-30 $1.23B $0.30B 24.11%
2021-03-31 $1.25B $0.32B 25.42%
2020-12-31 $1.23B $0.32B 25.97%
2020-09-30 $1.23B $0.34B 27.34%
2020-06-30 $1.25B $0.36B 28.86%
2020-03-31 $1.21B $0.31B 25.91%
2019-12-31 $1.18B $0.28B 24.04%
2019-09-30 $1.17B $0.30B 25.62%
2019-06-30 $1.11B $0.25B 22.53%
2019-03-31 $1.12B $0.28B 24.47%
2018-12-31 $1.15B $0.30B 25.91%
2018-09-30 $1.19B $0.31B 26.03%
2018-06-30 $1.23B $0.32B 26.35%
2018-03-31 $1.23B $0.32B 25.87%
2017-12-31 $1.23B $0.33B 26.98%
2017-09-30 $1.20B $0.55B 45.53%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $11.203B $1.669B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.304B 27.81
Zoetis (ZTS) United States $68.600B 24.89
Takeda Pharmaceutical (TAK) Japan $47.633B 9.72
Daiichi Sankyo, - (DSNKY) Japan $46.412B 23.79
BeOne Medicines - (ONC) Switzerland $32.657B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.720B 0.00
Summit Therapeutics (SMMT) United States $18.140B 0.00
Merck (MKKGY) Germany $16.327B 10.62
Shionogi (SGIOY) Japan $14.836B 14.86
United Therapeutics (UTHR) United States $13.859B 11.99
Neurocrine Biosciences (NBIX) United States $13.780B 41.11
IPSEN (IPSEY) France $11.603B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.707B 0.00
Eisai (ESAIY) $9.076B 10.24
Corcept Therapeutics (CORT) United States $7.332B 61.58
Stevanato Group S.p.A (STVN) Italy $7.105B 41.89
Ionis Pharmaceuticals (IONS) United States $6.793B 0.00
Grifols, S.A (GRFS) Spain $6.786B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.636B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.999B 14.25
Crinetics Pharmaceuticals (CRNX) United States $2.886B 0.00
Hypermarcas (HYPMY) Brazil $2.831B 21.29
Procaps Group, S.A (PROCF) Luxembourg $2.799B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.697B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.494B 8.35
Centessa Pharmaceuticals (CNTA) United Kingdom $2.218B 0.00
Ocular Therapeutix (OCUL) United States $2.178B 0.00
Dyne Therapeutics (DYN) United States $1.956B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.778B 0.00
Guardian Pharmacy Services (GRDN) United States $1.656B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.537B 0.00
Harrow (HROW) United States $1.443B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.420B 0.00
Xeris Biopharma Holdings (XERS) United States $1.276B 0.00
ARS Pharmaceuticals (SPRY) United States $1.271B 0.00
Evotec AG (EVO) Germany $1.246B 0.00
Collegium Pharmaceutical (COLL) United States $1.208B 6.60
Enliven Therapeutics (ELVN) United States $1.206B 0.00
Cronos Group (CRON) Canada $0.996B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.840B 0.00
Akebia Therapeutics (AKBA) United States $0.830B 0.00
ProKidney (PROK) United States $0.736B 0.00
Elite Pharmaceuticals (ELTP) United States $0.705B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.705B 7.27
Theravance Biopharma (TBPH) United States $0.704B 58.21
KalVista Pharmaceuticals (KALV) United States $0.680B 0.00
Organogenesis (ORGO) United States $0.650B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Bioventus (BVS) United States $0.599B 14.50
Tourmaline Bio (TRML) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.588B 7.27
Xencor (XNCR) United States $0.574B 0.00
USANA Health Sciences (USNA) United States $0.573B 11.75
Oruka Therapeutics (ORKA) United States $0.572B 0.00
Savara (SVRA) United States $0.565B 0.00
Nektar Therapeutics (NKTR) United States $0.558B 0.00
Zevra Therapeutics (ZVRA) United States $0.522B 0.00
Esperion Therapeutics (ESPR) United States $0.446B 0.00
Nanobiotix S.A (NBTX) France $0.443B 0.00
Aquestive Therapeutics (AQST) United States $0.382B 0.00
Aldeyra Therapeutics (ALDX) United States $0.351B 0.00
Altimmune (ALT) United States $0.327B 0.00
Larimar Therapeutics (LRMR) United States $0.324B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.99
4D Molecular Therapeutics (FDMT) United States $0.289B 0.00
AleAnna (ANNA) United States $0.281B 0.00
Galectin Therapeutics (GALT) United States $0.272B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.270B 0.00
Lexeo Therapeutics (LXEO) United States $0.257B 0.00
Korro Bio (KRRO) United States $0.222B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.214B 33.00
Lyell Immunopharma (LYEL) United States $0.213B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
OmniAb (OABI) United States $0.201B 0.00
Aclaris Therapeutics (ACRS) United States $0.199B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.171B 0.00
China SXT Pharmaceuticals (SXTC) China $0.169B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Avita Medical (RCEL) United States $0.117B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Wellgistics Health (WGRX) United States $0.113B 0.00
Surrozen (SRZN) United States $0.100B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.091B 20.69
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
Prelude Therapeutics (PRLD) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Gain Therapeutics (GANX) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.067B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 31.55
Jupiter Neurosciences (JUNS) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Plus Therapeutics (PSTV) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Century Therapeutics (IPSC) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Mangoceuticals (MGRX) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Ainos (AIMD) United States $0.019B 0.00
Incannex Healthcare (IXHL) Australia $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
ESSA Pharma (EPIX) Canada $0.011B 0.00
TNF Pharmaceuticals (TNFA) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Vyome Holdings (HIND) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Indivior (INDV) United States $0.000B 13.42
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.61
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00